Press Releases
Visiontree Supporting Value-Based Healthcare Initiatives in the Pharmaceutical Industry
Modular Visiontree solutions help optimize patient-reported outcomes tracking and integrated workflows with interoperability across disparate clinical systems
Munich, September 27, 2021—Visiontree, a Brainlab company, and leader in cloud-based, patient-reported outcomes, patient engagement, population health and multi-center research/registry solutions, is pleased to announce its collaboration with Mallinckrodt Pharmaceuticals for the Therakos Value-Based Healthcare (VBHC) initiative. The plan is to leverage the Visiontree flagship cloud-based application in select hospitals and clinics to collect clinician- and patient-reported outcomes as related to extracorporeal photopheresis (ECP) therapy.
The initiative is a multi-year program aimed to demonstrate the value of ECP therapy based on clinical outcomes, cost effectiveness, and productivity. Participating sites will leverage the Visiontree application to collect longitudinal, electronic clinician- and patient-reported outcomes measures (CROMs/PROMs). Hospitals will be able to utilize Visiontree interoperability solutions, including standardized HL7 FHIR® and application programming interface (API) suite to integrate to existing electronic health records (EHR) clinical systems. This deep interoperability allows for integrated data collection within the workflow, and real-world data sharing with the outcomes initiative.
“We are extremely honored for Visiontree to have the opportunity to support this initiative,” said Martin Pellinat, President and Founder, Visiontree Software, Inc. “We’re looking forward to supporting the overall goal of providing a centralized method to collect patient-level quality data using the Visiontree app. Our goal is to help med tech, pharma and academia drive care improvement using patient outcomes tracking.”
“The Therakos VBHC initiative will lay a foundation for a new model of tracking outcomes that will allow clinicians to improve care and optimize payment models,” said Florian Hugentobler, Mallinckrodt Pharmaceuticals, Regional Business Director Southern Europe, “Mallinckrodt is excited to take a leading role in delivering value-based care, a growing trend to increase quality while lowering total cost of care. We are delighted to be working with Visiontree to shape the future of healthcare around quality care, patient health and overall population health.”
After more than a decade in clinical use, Visiontree has documented improvements in the clinical and research workflows, including 40%+ improved compliance for capturing longitudinal patient-reported outcomes measures (PROMs), 10 minutes per-form staff-time saved, and 20% increased patient satisfaction.*
Overall, Visiontree helps providers by delivering risk-adjusted outcomes data, on an individual patient or an aggregate level, to allow for improved quality and efficiency of on-going patient care.
Visiontree is part of the Snke OS global digital health tech platform. Based in Munich, Germany, Snke OS is a secure B2B ecosystem that connects the dots between data sources, driving insights and analytics while creating technologies that help customers lead fast and lead first. Snke OS is transforming healthcare using digital twin models, deep tech, AI, and big data to improve industry best practices in the patient journey.
About Visiontree
Visiontree Software, Inc., a Brainlab company and part of the Snke OS ecosystem, is a leader in cloud- based, patient-centered outcomes data management systems. The Visiontree patient data management and workflow application is implemented at over 600 sites globally with 2.5M+ patients. The company’s platform is used for multi-center research, registries, and population health initiatives across multiple domains. The Visiontree customer base consists of leading academic and community centers, research organizations and medical societies globally including more than 10 thought leading centers in the Europe and Asia Pacific region, as well as 17 of the top 20 U.S. News and World Report Hospitals. To learn more, visit Visiontree and follow us on LinkedIn and Twitter.
About Brainlab
Brainlab is a digital medical technology pioneer founded in 1989 and headquartered in Munich. The company employs more than 1,800 people in 21 offices around the globe. Brainlab serves physicians, medical professionals and their patients in over 5,800 hospitals in 117 countries.
Brainlab creates software-driven medical solutions that digitize, automate and optimize clinical workflows for neurosurgery, spine, trauma, craniomaxillofacial (CMF), general and vascular surgery as well as radiotherapy and radiosurgery. Core products center around surgical navigation, radiotherapy, digital operating room integration, and information and knowledge exchange. The Brainlab open framework operating system will allow third parties to develop medical applications to further advance the field of spatial computing and mixed reality.
Brainlab is dedicated to creating an impact in healthcare. The company connects opportunities from emerging digital technologies to transform healthcare at scale and help improve the lives of patients worldwide. For more information, please visit Brainlab and follow on LinkedIn, Twitter, Facebook and Instagram.
Press Contact
Global
Bernadette Erwig
Communications and PR Manager
+49 89 99 1568 0
[email protected]
USA
Debbra Verard
Director, Marketing and Communications, Brainlab
+1 (708) 409-1343
[email protected]